Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2020 Apr 1;29(12):2495–2503. doi: 10.1158/1055-9965.EPI-20-0005

Table 2.

Candidate biomarkers for hepatocellular carcinoma early detection

Biomarker Phase of
Development
Early Detection
Performance
AUROC for
early detection
Alpha fetoprotein (AFP)(20-25) 5 Sensitivity: 39-64%
Specificity: 76%-97%
0.75-0.82
Lens culinaris agglutinin-reactive AFP (AFP-L3)(20,33) 2/3 Sensitivity: 49-62%
Specificity: 90%
0.66-0.76
Des-gamma carboxyprothrombin (DCP)(20,33) 2/3 Sensitivity: 34-40%
Specificity: 81-98%
0.72
Osteopontin(38,40,41) 2 Sensitivity: 49%
Specificity: 72%
0.73
Midikine(44) 2/3 Sensitivity: 87%
Specificity: 90%
0.923
Dikkopf-1(45,46) 2 Sensitivity: 41%-74%
Specificity: 87%
0.61-0.88
Glypican-3(50-52) 2 Sensitivity: 55%
Specificity: >95%
0.793
Alpha-1 fucosidase(53) 2 Sensitivity: 56%
Specificity: 69%
0.506
Golgi Protein-73(58,59) 2 Sensitivity: 62%-79%
Specificity: 62%-88%
Not available
Squamous cell carcinoma antigen (SCCA)(60-63) 2 Data for early stage HCC not available Data for early stage HCC not available